GleamWall
中文EN

NPCE NeuroPace Inc

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1528287 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.9%
TTM net income YoY21.1%
TTM EPS YoY25.3%
Revenue 3-yr CAGR16.3%
Net income 3-yr CAGR—

Margins

Gross margin81.4%
Operating margin-15.4%
Net margin-20.0%
FCF margin-13.1%
EBITDA margin-15.0%

Returns

ROE-126.1%
ROA-18.7%
ROIC (approx.)-19.7%
Asset turnover0.94x

Leverage & solvency

Liabilities / assets87.9%
Debt / equity5.15x
Current ratio5.26x
Interest coverage-2.34x

Cash quality & payout

Operating cash flow / net income0.64x
Accruals ratio-6.8%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$99.99M$79.91M
Cost of revenue$22.77M$20.82M
Gross profit$77.22M$59.09M
R&D expense$27.89M$23.65M
SG&A expense$19.09M$17.43M
Operating income-$16.34M-$21.67M
Interest expense$7.46M$8.80M
Income tax$0—
Net income-$21.46M-$27.14M
EBITDA-$16.10M-$21.46M
EPS (basic)-0.66-0.93
EPS (diluted)-0.66-0.93
Dividends declared per share0.000.00
Weighted avg. shares (diluted)32.72M29.13M
Balance sheet
Cash & equivalents$21.69M$13.55M
Short-term investments$39.37M$39.33M
Receivables$12.94M$12.85M
Inventory$14.86M$13.38M
Current assets$94.07M$81.34M
PP&E, net$1.12M$1.05M
Total assets$105.56M$94.65M
Current liabilities$17.81M$15.16M
Long-term debt$58.88M$59.52M
Total debt$58.88M$59.52M
Total liabilities$86.53M$86.63M
Shareholders' equity$19.03M$8.01M
Net debt$37.19M$45.97M
Shares outstanding33.57M30.15M
Cash flow statement
Operating cash flow-$11.01M-$17.95M
Capital expenditure$332,000$306,000
Free cash flow-$11.34M-$18.25M
Investing cash flow-$332,000$8.99M
Financing cash flow$19.60M$4.33M
Depreciation & amortization$238,000$207,000
Stock-based compensation$11.09M$10.28M
Share buybacks$49.55M$0

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.